Metropolis Healthcare grants stock benefits to employees

Metropolis Healthcare Ltd. has approved the grant of various stock benefits to its eligible employees following a meeting of the Nomination and Remuneration Committee on November 4, 2025. The grants include 18,232 units under the Metropolis – Restrictive Stock Unit Plan, 2020, and an additional 10,107 units under the Metropolis – Restrictive Stock Units Plan, 2025. Furthermore, 228,840 options have been granted under the Metropolis – Employees Stock Options Plan, 2025.

These schemes comply with SEBI (Share-Based Employee Benefits) Regulations, 2021. The units under the Restrictive Stock Unit Plans have a face value of INR 2/- per unit, while the Employees Stock Options Plan has a pricing formula of INR 1,648.24/- per option. All granted benefits are subject to a minimum vesting period of one year, extending up to four years, and can be exercised within a maximum period of five years from the vesting date.

The decision reflects Metropolis Healthcare’s strategy to incentivize and retain its employees through ownership in the company.